Abutrial is a medication that combines two active ingredients: buprenorphine and naloxone. It is primarily used in the treatment of opioid dependence, helping to reduce withdrawal symptoms and cravings associated with opioid addiction. Buprenorphine acts as a partial opioid agonist, while naloxone is an opioid antagonist that helps prevent misuse of the medication. This combination aims to provide a safer alternative for individuals seeking recovery from opioid use disorder.